Pityriasis lichenoides: Pathophysiology, classification, and treatment

American Journal of Clinical Dermatology

Volumn 8, Issue 1, 2007, Pages 29-36

  Khachemoune, Amor ^a   Blyumin, Marianna L ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; COAL TAR; CORTICOSTEROID; CYCLOSPORIN A; DAPSONE; EMOLLIENT AGENT; ERGOCALCIFEROL; ERYTHROMYCIN; ETRETIN; GAMMA GLOBIN; GOLD; IMMUNOGLOBULIN G; LAMIVUDINE; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE; RETINOID; SAQUINAVIR; TACROLIMUS; TETRACYCLINE; TIABENDAZOLE;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEBRILE ULCERONECROTIC MUCHA HABERMANN DISEASE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; HYPERSENSITIVITY REACTION; HYPOPIGMENTATION; IMMUNE DYSREGULATION; INCIDENCE; LYMPHOCYTIC INFILTRATION; MACULOPAPULAR RASH; PAPULE; PARAKERATOSIS; PARAPSORIASIS LICHENOIDES; PATHOPHYSIOLOGY; PHOTOTHERAPY; PITYRIASIS LICHENOIDES; PITYRIASIS LICHENOIDES VARIOLIFORMIS ACUTA; PITYRIASIS ROSEA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RASH; REMISSION; REVIEW; SKIN BIOPSY; SKIN NECROSIS; ULTRAVIOLET A RADIATION; XEROSIS; ADOLESCENT; CASE REPORT; CLASSIFICATION; MALE; METHODOLOGY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PHOTOTHERAPY; PITYRIASIS LICHENOIDES;

EID: 34247274087     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200708010-00004     Document Type: Review

References (64)

1. Cozzio A, Hafner J, Kempf W, et al. Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol 2004; 51: 1014-7
2. Daoud MS, Pittelkow MR. Pityriasis lichenoides. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick's dermatology in general medicine. 6th edition. New York: McGraw-Hill, Inc., 2003: 456-62
3. Wood GS, Reizner G. Other papulosquamous disorders. In: Bolognia JL, Jorizzo J, Rapini R, editors. Dermatology. London: CV Mosby, 2003: 151-63
4. Ricci G, Patrizi A, Misciali D, et al. Pathological case of the month: febrile Mucha-Habermann disease. Arch Pediatr Adolesc Med 2001; 155: 195-6
5. Lichenoides and interface dermatoses. In: McKee PH, Calonje E, Granter SR, editors. Pathology of the skin with clinical correlations. 3rd edition. London: Mosby Ltd, 2005: 217-60
6. Horn TD. Inflammatory reactions in the skin. In: Barnhill RL. Textbook of dermatopathology. New York: McGraw-Hill, Inc, 1998: 31-54
7. Gelmetti C, Rigoni C, Alessi E, et al. Pityriasis lichenoides in children: a long term follow-up of eighty-nine cases. J Am Acad Dermatol 1990; 23: 473-8
8. Tsianakas A, Hoeger PH. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumor necrosis factor-alpha. Br J Dermatol 2005; 152: 794-9
9. Tomasini D, Zampatti C, Palmedo G, et al. Cytotoxic mycosis fungoides evolving from pityriasis lichenoides chronica in a seventeen-year-old girl. Dermatology 2002; 205: 176-9
10. Rivera R, Ortiz J, Rodriguez-Peralto L, et al. Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with atypical cells. Int J Dermatol 2003; 42: 26-8
11. Degos R, Duperrat B, Daniel F. Le parapsoriasis ulceronecrotique hyperthermique. Ann Dermatol Venereol 1966; 93: 481-96
12. Yang C, Lee J, Chen W. Febrile ulceronecrotic Mucha-Habermann disease with extensive skin necrosis in intertriginous areas. Eur J Dermatol 2003; 13: 493-6
13. Yanaba K, Ito M, Sasaki H, et al. A case of febrile ulceronecrotic Mucha-Habermann disease requiring debridement of necrotic skin and epidermal autograft. Br J Dermatol 2002; 147: 1249-53
14. Tsuji T, Kasamatsu M, Yokota M, et al. Mucha-Habermann disease and its febrile ulceronecrotic variant. Cutis 1996; 58: 123-31
15. Herron MD, Bohnsack JF, Vanderhooft SL. Septic, CD-30 positive febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta. Pediatr Dermatol 2005; 22: 360-5
16. Malnar T, Milaver-Puretic V, Rados J, et al. Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with fatal outcome. J Eur Acad Dermatol Venereol 2006; 20: 303-7
17. Miyamoto T, Takayama N, Kitada S, et al. Febrile ulceronecrotic Mucha-Habermann disease: a case report and a review of the literature. J Clin Pathol 2003; 56: 795-7
18. Patel DG, Kihiczak G, Schwartz RA, et al. Pityriasis lichenoides. Cutis 2000; 65: 17-20, 23
19. Henning JS. Pityriasis lichenoides chronica. Dermatol Online J 2004; 10: 8
20. Ko J, Seong J, Suh K, et al. Pityriasis lichenoides-like mycosis fungoides in children. Br J Dermatol 2000; 142: 347-52
21. Slater DN. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphoma: a practical marriage of two giants. Br J Dermatol 2005; 153: 874-80
22. Varga FJ, Vonderheid EC, Olbricht SM, et al. Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Am J Pathol 1990; 136: 979-87
23. Panhans A, Bodemer C, Macinthyre E, et al. Pityriasis lichenoides of childhood with atypical CD30-positive cells and clonal T-cell receptor gene rearrange-ments. J Am Acad Dermatol 1996; 35: 489-90
24. Zlatkov NB, Adreev VC. Toxoplasmosis and pityriasis lichenoides. Br J Dermatol 1972; 87: 114-6
25. Tomasini D, Tomasini CF, Cerri A, et al. Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases. J Cutan Pathol 2004; 31: 531-8
26. Boralevi F, Cotto E, Baysse L, et al. Is varicella zoster virus involved in the etiopathogeny of pityriasis lichenoides? J Invest Dermatol 2003; 121: 647-8
27. Klein PA, Jones EC, Nelson JL, et al. Infectious causes of pityriasis lichenoides: a case of fulminant infectious mononucleosis. J Am Acad Dermatol 2003; 49: S151-3
28. Tsai KS, Hsieh HJ, Chow KC, et al. Detection of cytomegalovirus infection in a patient with febrile ulceronecrotic Mucha-Habermann's disease. Int J Dermatol 2001; 40: 694-8
29. Rongioletti F, Delmonte S, Rebora A. Pityriasis lichenoides and acquired toxoplasmosis. Int J Dermatol 1999; 38: 372-4
30. Smith KJ, Nelson A, Skelton H, et al. Pityriasis lichenoides et varioliformis acuta in HIV-1+ patient: a marker of early stage disease. Int J Dermatol 1997; 36: 104-9
31. Kawamura K, Tsuji T, Kuwabara Y. Mucha-Habermann disease-like eruptions due to tegafur. J Dermatol 1999; 26: 164-7
32. Hollander A, Grots IA. Mucha-Habermann disease following estrogen-progester-one therapy. Arch Dermatol 1973; 107: 465
33. Stosiek N, Peters KP, von den Driesch P. Pityriasis-lichenoides-et- varioliformis-acuta-like drug exanthema caused by astemizole. Hautarzt 1993; 44: 235-7
34. Tanaka M. Drug-induced pityriasis lichenoides et varioliformis acuta. Rinsho Hifuka 1990; 44: 307-10
35. Nishimura M, Matsuda T, Hori Y. Mucha-Habermann disease resolves after tonsillectomy. Int J Dermatol 1991; 30: 896-7
36. Zechini B, Teggi A, Antonelli M, et al. A case report of pityriasis lichenoides in a patient with chronic hepatitis C. J Infect 2005; 51: e23-5
37. Clayton R, Haffenden G. An immunofluorescence study of pityriasis lichenoides. Br J Dermatol 1978; 99: 491-3
38. Clayton R, Haffenden G, Du Vivier A, et al. Pityriasis lichenoides: an immune complex disease. Br J Dermatol 1977; 97: 629-34
39. Muhlbauer JE, Bhan AK, Harrist TJ, et al. Immunopathology of pityriasis liche-noides acuta. J Am Acad Dermatol 1984; 10: 783-95
40. Khosrotehrani K, Guegan S, Fraitag S, et al. Presence of chimeric maternally derived keratinocytes in cutaneous inflammatory diseases of children: the example of pityriasis lichenoides. J Invest Dermatol 2006; 126: 345-8
41. Dereure O, Levi E, Kadin ME. T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol 2000; 136: 1483-6
42. Margo C, Crowson NA, Kovatich A, et al. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol 2002; 33: 788-95
43. Weinberg JM, Kristal L, Chooback L, et al. The clonal nature of pityriasis lichenoides. Arch Dermatol 2002; 138: 1063-7
44. Black MM. Lymphomatoid papulosis and pityriasis lichenoides: are they related? Br J Dermatol 1982; 106: 717-21
45. Niemczyk UM, Zollner TM, Wolter M, et al. The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 11-year-old girl. Br J Dermatol 1997; 137: 983-7
46. Panizzon RG, Speich R, Dazzi H. Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphoma of the skin. Dermatology 1992; 184: 65-9
47. Fortson JS, Schroeter AL, Esterly NB. Cutaneous T-cell lymphoma (parapsoriasis en plaque): an association with pityriasis lichenoides et varioliformis acuta in young children. Arch Dermatol 1990; 126: 1449-53
48. Wenzel J, Gutgemann I, Distelmaier M, et al. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides. J Am Acad Dermatol 2005; 53: 422-7
49. Dupont C. Pityriasis lichenoides in a family. Br J Dermatol 1995; 133: 338-9
50. Garcia B, Connelly EA, Newbury R, et al. Pityriasis lichenoides and idiopathic thrombocytopenia purpura in a young girl. Pediatr Dermatol 2006; 23: 21-3
51. Kempf W, Kutzner H, Kettelhack G, et al. Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: a case report and review of the literature on paraneoplastic reactions of skin in lymphoma and leukemia. Br J Dermatol 2005; 152: 1327-31
52. Brazzini B, Ghersetich I, Urso C, et al. Pityriasis lichenoides et varioliformis acuta during pregnancy. J Eur Acad Dermatol Venereol 2001; 15: 458-60
53. Eskandar MA. Pityriasis lichenoides et varioliformis acuta in pregnancy. Saudi Med J 2001; 22: 1127-9
54. Milligan A, Johnston G. Pityriasis lichenoides chronica and pityriasis lichenoides et varioliformis acuta. In: Lebwohl M, Berth-Jones J, Heymann WR, editors. Treatment of skin disease. London: CV Mosby, 2002: 472-7
55. Pinton PC, Capezzera R, Zane C, et al. Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002; 47: 410-4
56. Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol 1996; 13: 406-9
57. Pavlotsky F, Baum S, Barzilai A, et al. UVB therapy of pityriasis lichenoides: our experience with 29 patients. J Eur Acad Dermatol Venereol 2006; 20: 642-7
58. Luberti AA, Rabinowitz LG, Ververeli KO. Severe febrile Mucha-Habermann's disease in children: case report and review of the literature. Pediatr Dermatol 1991; 8: 51-7
59. Maekawa Y, Nakamura T, Nogami R. Febrile ulceronecrotic Mucha-Habermann's disease. J Dermatol 1994; 21: 46-9
60. Griffiths JK. Successful long-term use of cyclosporin A in HIV-induced pityriasis lichenoides chronica. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 396-7
61. Simon D, Boudny C, Nievergelt H, et al. Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol 2004; 150: 1033-5
62. Ito N, Ohshima A, Hashizume H, et al. Febrile ulceronecrotic Mucha-Habermann's disease managed with methylprednisolone semipulse and subsequent methotrexate therapies. J Am Acad Dermatol 2003; 49: 1142-8
63. Nakamura S, Nishihara K, Nakajima K, et al. Febrile ulceronecrotic Mucha-Habermann's disease and its successful therapy with DDS. J Dermatol 1989; 13: 381-4
64. Suarez J, Lopez B, Villalba R, et al. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature. Dermatology 1996; 192: 277-9